Candriam SCA’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-70,000
| Closed | -$176K | – | 808 |
|
2020
Q3 | $176K | Sell |
70,000
-1,159,346
| -94% | -$2.91M | ﹤0.01% | 759 |
|
2020
Q2 | $16.7M | Buy |
+1,229,346
| New | +$16.7M | 0.18% | 144 |
|
2019
Q4 | – | Sell |
-300,000
| Closed | -$1.18M | – | 788 |
|
2019
Q3 | $1.18M | Hold |
300,000
| – | – | 0.02% | 581 |
|
2019
Q2 | $1.45M | Hold |
300,000
| – | – | 0.02% | 581 |
|
2019
Q1 | $2.46M | Hold |
300,000
| – | – | 0.03% | 453 |
|
2018
Q4 | $1.66M | Buy |
300,000
+230,000
| +329% | +$1.27M | 0.03% | 496 |
|
2018
Q3 | $618K | Buy |
+70,000
| New | +$618K | 0.01% | 687 |
|
2015
Q1 | – | Sell |
-76,485
| Closed | -$890K | – | 636 |
|
2014
Q4 | $890K | Buy |
+76,485
| New | +$890K | 0.02% | 453 |
|